NCT04322032 - Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 6, 2020

Primary Completion Date

May 12, 2020

Study Completion Date

May 18, 2020

Conditions

Type 2 Diabetes

Interventions

DRUG

Reference drug

D759 Tab. 1 Tab. and D308 Tab. 1 Tab.(Total 2 Tab.), Single oral administration under fasting condition.

DRUG

Test drug

CKD-389 Tab. 1 Tab.(Total 1 Tab.), Single oral administration under fasting condition.

Trial Locations (1)

Chonbuk National University Hospital, Jeonju